v3.26.3
Consolidated Statements of Stockholders' Deficiency - USD ($)
 12 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Balance $ (5,116,000) $ (2,864,000)
Share-based compensation expense - stock options 197,000 144,000
Share-based compensation expense - restricted stock units   3,000
Issuance of common stock upon the delivery of restricted stock units  
Net loss (2,483,000) (2,399,000)
Issuance of common stock in private placement, net 1,003,000  
Balance (6,399,000) (5,116,000)
Common Stock [Member]    
Balance $ 1,119,000 $ 1,119,000
Balance, shares 111,886,473 111,856,473
Share-based compensation expense - stock options
Share-based compensation expense - restricted stock units  
Issuance of common stock upon the delivery of restricted stock units [1]  
Issuance of common stock upon the delivery of restricted stock units, shares   30,000
Net loss
Issuance of common stock in private placement, net $ 182,000  
Issuance of common stock in private placement, net, shares 18,131,096  
Balance $ 1,301,000 $ 1,119,000
Balance, shares 130,017,569 111,886,473
Additional Paid-in Capital [Member]    
Balance $ 132,759,000 $ 132,612,000
Share-based compensation expense - stock options 197,000 144,000
Share-based compensation expense - restricted stock units   3,000
Issuance of common stock upon the delivery of restricted stock units [1]  
Net loss
Issuance of common stock in private placement, net 821,000  
Balance 133,777,000 132,759,000
Retained Earnings [Member]    
Balance (138,994,000) (136,595,000)
Share-based compensation expense - stock options
Share-based compensation expense - restricted stock units  
Issuance of common stock upon the delivery of restricted stock units  
Net loss (2,483,000) (2,399,000)
Issuance of common stock in private placement, net  
Balance $ (141,477,000) $ (138,994,000)
[1] Less than $1,000